Stay updated on IO102/IO103 Combo + Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the IO102/IO103 Combo + Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IO102/IO103 Combo + Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A new revision v3.6.0 was added and the study now shows no longer looking for participants, replacing the previous revision v3.5.5.
    Difference
    0.3%
    Check dated 2026-06-13T05:21:12.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The history now shows a new revision label, v3.5.5, replacing the previous v3.5.4, indicating an update to the study record.
    Difference
    0.1%
    Check dated 2026-06-05T22:14:48.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    A new revision entry 'Revision: v3.5.4' has been added to the history, replacing the previous revision tag. This documents the latest update to the study record's revision metadata.
    Difference
    0.1%
    Check dated 2026-05-15T16:23:05.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The page’s UI revision indicator was updated from v3.5.2 to v3.5.3, reflecting a software/version change for the ClinicalTrials.gov record history display.
    Difference
    0.1%
    Check dated 2026-04-24T06:14:46.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and removed Revision: v3.5.0 in the study record history.
    Difference
    0.1%
    Check dated 2026-04-17T02:43:20.000Z thumbnail image
  8. Check
    65 days ago
    Change Detected
    Summary
    Added a new 'Results Submission Events' section to the study record history, displaying events related to results submission.
    Difference
    0.1%
    Check dated 2026-04-09T21:41:48.000Z thumbnail image

Stay in the know with updates to IO102/IO103 Combo + Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IO102/IO103 Combo + Pembrolizumab in Melanoma Clinical Trial page.